The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics

Systemic lupus erythematosus (SLE) is a kind of chronic diffuse connective tissue illness characterized by multisystem and multiorgan involvement, repeated recurrence and remission, and the presence of a large pool of autoantibodies in the body. Although the exact cause of SLE is not thoroughly reve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xirui Guo, Xuerong Yang, Qi Li, Xiaoyan Shen, Huiyun Zhong, Yong Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c29208ff0fc74e9f9571fb23618083e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c29208ff0fc74e9f9571fb23618083e1
record_format dspace
spelling oai:doaj.org-article:c29208ff0fc74e9f9571fb23618083e12021-11-30T14:06:28ZThe Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics1663-981210.3389/fphar.2021.759095https://doaj.org/article/c29208ff0fc74e9f9571fb23618083e12021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.759095/fullhttps://doaj.org/toc/1663-9812Systemic lupus erythematosus (SLE) is a kind of chronic diffuse connective tissue illness characterized by multisystem and multiorgan involvement, repeated recurrence and remission, and the presence of a large pool of autoantibodies in the body. Although the exact cause of SLE is not thoroughly revealed, accumulating evidence has manifested that intake of probiotics alters the composition of the gut microbiome, regulating the immunomodulatory and inflammatory response, which may be linked to the disease pathogenesis. Particularly, documented experiments demonstrated that SLE patients have remarkable changes in gut microbiota compared to healthy controls, indicating that the alteration of microbiota may be implicated in different phases of SLE. In this review, the alteration of microbiota in the development of SLE is summarized, and the mechanism of intestinal microbiota on the progression of immune and inflammatory responses in SLE is also discussed. Due to limited reports on the effects of probiotics supplementation in SLE patients, we emphasize advancements made in the last few years on the function and mechanisms of probiotics in the development of SLE animal models. Besides, we follow through literature to survey whether probiotics supplements can be an adjuvant therapy for comprehensive treatment of SLE. Research has indicated that intake of probiotics alters the composition of the gut microbiome, contributing to prevent the progression of SLE. Adjustment of the gut microbiome through probiotics supplementation seems to alleviate SLE symptoms and their cardiovascular and renal complications in animal models, marking this treatment as a potentially novel approach.Xirui GuoXuerong YangQi LiXiaoyan ShenHuiyun ZhongHuiyun ZhongYong YangFrontiers Media S.A.articleautoimmunitymicrobiotaprobioticssystemic lupus erythematosusinflammationTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic autoimmunity
microbiota
probiotics
systemic lupus erythematosus
inflammation
Therapeutics. Pharmacology
RM1-950
spellingShingle autoimmunity
microbiota
probiotics
systemic lupus erythematosus
inflammation
Therapeutics. Pharmacology
RM1-950
Xirui Guo
Xuerong Yang
Qi Li
Xiaoyan Shen
Huiyun Zhong
Huiyun Zhong
Yong Yang
The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
description Systemic lupus erythematosus (SLE) is a kind of chronic diffuse connective tissue illness characterized by multisystem and multiorgan involvement, repeated recurrence and remission, and the presence of a large pool of autoantibodies in the body. Although the exact cause of SLE is not thoroughly revealed, accumulating evidence has manifested that intake of probiotics alters the composition of the gut microbiome, regulating the immunomodulatory and inflammatory response, which may be linked to the disease pathogenesis. Particularly, documented experiments demonstrated that SLE patients have remarkable changes in gut microbiota compared to healthy controls, indicating that the alteration of microbiota may be implicated in different phases of SLE. In this review, the alteration of microbiota in the development of SLE is summarized, and the mechanism of intestinal microbiota on the progression of immune and inflammatory responses in SLE is also discussed. Due to limited reports on the effects of probiotics supplementation in SLE patients, we emphasize advancements made in the last few years on the function and mechanisms of probiotics in the development of SLE animal models. Besides, we follow through literature to survey whether probiotics supplements can be an adjuvant therapy for comprehensive treatment of SLE. Research has indicated that intake of probiotics alters the composition of the gut microbiome, contributing to prevent the progression of SLE. Adjustment of the gut microbiome through probiotics supplementation seems to alleviate SLE symptoms and their cardiovascular and renal complications in animal models, marking this treatment as a potentially novel approach.
format article
author Xirui Guo
Xuerong Yang
Qi Li
Xiaoyan Shen
Huiyun Zhong
Huiyun Zhong
Yong Yang
author_facet Xirui Guo
Xuerong Yang
Qi Li
Xiaoyan Shen
Huiyun Zhong
Huiyun Zhong
Yong Yang
author_sort Xirui Guo
title The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
title_short The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
title_full The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
title_fullStr The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
title_full_unstemmed The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
title_sort microbiota in systemic lupus erythematosus: an update on the potential function of probiotics
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c29208ff0fc74e9f9571fb23618083e1
work_keys_str_mv AT xiruiguo themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT xuerongyang themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT qili themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT xiaoyanshen themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT huiyunzhong themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT huiyunzhong themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT yongyang themicrobiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT xiruiguo microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT xuerongyang microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT qili microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT xiaoyanshen microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT huiyunzhong microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT huiyunzhong microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
AT yongyang microbiotainsystemiclupuserythematosusanupdateonthepotentialfunctionofprobiotics
_version_ 1718406529860763648